PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26343583-3	2015	LY3009120 induces BRAF-CRAF dimerization but inhibits the phosphorylation of downstream MEK and ERK, suggesting that it effectively inhibits the kinase activity of BRAF-CRAF heterodimers.	LY3009120	0-9	mitogen-activated protein kinase kinase 7	Homo sapiens	88-91	
34837846-9	2022	MEK inhibitor showed synergy with multikinase inhibitor ponatinib, ABL inhibitor nilotinib, PI3K/mTOR inhibitor pictilisib, and pan-RAF inhibitor LY3009120.	LY3009120	146-155	mitogen-activated protein kinase kinase 7	Homo sapiens	0-3	
34539849-7	2021	This effect was caused by a decrease in proliferation, induction of apoptosis, and cell growth arrest through a decrease in phosphorylated MEK and ERK along with a cytotoxic response occurring specifically for the RAS mutation of the pan-RAF inhibitor LY3009120.	LY3009120	252-261	mitogen-activated protein kinase kinase 7	Homo sapiens	139-142